NEFL and Alzheimer disease: Moreover, plasma GFAP can more accurately distinguish Aβ-positive from Aβ-negative individuals compared to CSF GFAP [90] and increases even before plasma p-tau and NfL in sporadic [91] and familial forms of AD [92].